Jupiter Asset Management LTD Puma Biotechnology, Inc. Transaction History

Jupiter Asset Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$6.63 - $9.39 $4.28 Million - $6.06 Million	-645,871 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$8.98 - $11.6 $381,425 - $492,710	-42,475 Reduced 6.17%	645,871 $5.92 Million
Q1 2021 May 12, 2021	SELL	$9.38 - $13.63 $376,081 - $546,481	-40,094 Reduced 5.5%	688,346 $6.69 Million
Q4 2020 Feb 10, 2021	BUY	$7.78 - $12.13 $365,932 - $570,534	47,035 Added 6.9%	728,440 $7.47 Million
Q3 2020 Nov 10, 2020	BUY	$9.5 - $11.14 $6.47 Million - $7.59 Million	681,405 New	681,405 $6.86 Million

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.